Allena Pharmaceuticals, Inc. Change in other assets and liabilities

Change in other assets and liabilities of ALNA for past 10 years: annual, quarterly and twelve month trailing (TTM) including Change in other assets and liabilities growth rates and interactive chart.


Highlights and Quick Summary

  • Change in other assets and liabilities for the quarter ending March 31, 2022 was $-8.36 Million (a 465.07% increase compared to previous quarter)
  • Year-over-year quarterly Change in other assets and liabilities decreased by -1743.03%
  • Annual Change in other assets and liabilities for 2021 was $-811 Thousand (a -192.79% decrease from previous year)
  • Annual Change in other assets and liabilities for 2020 was $874 Thousand (a -1206.33% decrease from previous year)
  • Annual Change in other assets and liabilities for 2019 was $-79 Thousand (a -93.93% decrease from previous year)
  • Twelve month Change in other assets and liabilities ending March 31, 2022 was $-9.16 Million (a 1029.1% increase compared to previous quarter)
  • Twelve month trailing Change in other assets and liabilities decreased by -7367.46% year-over-year
Trailing Change in other assets and liabilities for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
$-9.16 Million $-811 Thousand $-253 Thousand $126 Thousand
Visit stockrow.com/ALNA for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Change in other assets and liabilities of Allena Pharmaceuticals, Inc.

Most recent Change in other assets and liabilitiesof ALNA including historical data for past 10 years.

Interactive Chart of Change in other assets and liabilities of Allena Pharmaceuticals, Inc.

Allena Pharmaceuticals, Inc. Change in other assets and liabilities for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-8.36
2021 $-1.48 $0.18 $0.51 $-0.02 $-0.81
2020 $-0.92 $0.56 $0.25 $0.63 $0.87
2019 $-1.03 $1.44 $-2.26 $1.24 $-0.08
2018 $-0.58 $-1.35 $0.06 $0.57 $-1.3
2017 $-0.96 $-0.2 $0.02 $0.07 $-1.07
2016 $0.28 $0.16
2015 $-0.66

Business Profile of Allena Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology
Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.